Ari Meguerditchian, MD, MSc, FRCS(C), FACS
Research Institute of the McGill University Health Centre
Regular Member Cancer Health Outcomes
McGill University Health Centre (MUHC)
Surgical Oncologist, McGill University Health Centre
Assistant Professor, Departments of Surgery and Oncology, McGill University Member, Clinical and Health Informatics Research Group, McGill University
My research focuses on developing tools that ensure quality in the delivery of cancer care across the community. Advances in science have made this major health problem a treatable disease, yet up to a third of patients diagnosed with cancer do not receive recommended care. These deviations from best care have been documented for all aspects of cancer management, from screening and diagnosis, to post-treatment follow-up and end-of-life care. They impact recurrence, survival, quality of life and costs. Deviations in cancer care quality raise important questions about translating scientific knowledge into clinical practice. Interventions to manage these deviations are currently challenged by the lack of an integrated cancer care monitoring strategy. Health informatics technology (HIT) represents the ideal tool to address this challenge. We aim to develop informatic tools that would allow us to integrate currently existing and separately maintained clinical, service, and competency data repositories using HIT.
- treatment adherence and persistence
- post-operative outcomes
- guideline compliance
- health informatics technology (HIT)
- medication reconciliation
- health service utilization
Health outcomes, cancer, quality of care, treatment guidelines, health informatics tools
Meguerditchian AN, Dauphinee D, Girard N, Eguale T, Riedel KE, Jacques A, Meterissian SM, Buckeridge DL, Abrahamowicz M, Tamblyn R. Do Physician Communication Skills Influence Screening Mammography Utilization? BMC Health Services Research, 2012 July 25(12): 219
Krotneva S, Reidel KE, Verma A, Mayo N, Tamblyn R, Meguerditchian AN. Factors Influencing Quality of Local Management of Ductal Carcinoma in Situ: A Cohort Study. Current Oncology 2013 June 20(3): e212-222.
Krotneva S, Reidel K, Nassif M, Mayo N, Tamblyn R, Meguerditchian AN. Rates and Predictors of Consideration for Adjuvant Radiotherapy among high-risk Breast Cancer patients: A Cohort Study. Breast Cancer Research and Treatment 2013 July 140(2): 397-405.
Tamblyn R, Huang AH, Meguerditchian AN, Winslade NE, Rochefort C, Buckeridge D, Jacques A, Naicker K, Reidel KE, Eguale T, Forster A. Using Novel Canadian Resources to Improve Medication Reconciliation at Discharge: Study Protocol for a Randomized Controlled Trial. Trials. 2012 August; 15:150. 13:150.
Meguerditchian AN, Stewart A, Malin K, Roistacher J, Watroba N, Cropp M, Edge SB. Claims Data Linked to Hospital Registry Data Enhance Evaluation of the Quality of Care of Breast Cancer. Journal of Surgical Oncology 2010; 101: 593-599.